Federal contract award
W81K0223P0100
ONCOTYPE DX GENOMIC TESTING SERVICES FOR MADIGAN ARMY MEDICAL CENTER, JBLM, WA.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | DEFENSE HEALTH AGENCY HCD WEST |
| NAICS | 621511 — Medical Laboratories |
| PSC | Q301 — Reference Laboratory Testing |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $283.2K |
| Current contract value | $407.2K |
| Potential contract value / ceiling | $531.1K |
| Start date | Oct 1, 2023 |
| Current end date | Sep 30, 2027 |
| Potential end date | Sep 30, 2028 |
| Latest award activity | Jun 10, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 13 of 13 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 10, 2026 | P00012 | $0 | COLOGUARD TEST, ONCOGUARD LIVER TEST, ONCOTYPE BREAST TEST, ONCOTYPE COLON TEST, ONCOTYPE BREAST TEST, ONCOTYPE PANELS TEST, ONCOTYPE MICRODISSECTION TEST |
| Apr 8, 2026 | P00011 | $0 | COLOGUARD TEST, ONCOGUARD LIVER TEST, ONCOTYPE BREAST TEST, ONCOTYPE COLON TEST, ONCOTYPE BREAST TEST, ONCOTYPE PANELS TEST, ONCOTYPE MICRODISSECTION TEST |
| Mar 24, 2026 | P00010 | $0 | ONCOTYPE DX LAB TESTING MAMC |
| Jan 14, 2026 | P00009 | $124.0K | ONCOTYPE DX LAB TESTING MAMC |
| Aug 12, 2025 | P00008 | $0 | ONCOTYPE DX LAB TESTING MAMC |
| Jun 26, 2025 | P00007 | $-27.0K | ONCOTYPE DX LAB TESTING MAMC |
| Dec 10, 2024 | P00006 | $-61.8K | ONCOTYPE TESTS - DEOBLIGATE FY24 FUNDS |
| Oct 29, 2024 | P00005 | $124.0K | ONCOTYPE DX-BREAST TEST ADD FY25 FUNDING |
| Aug 21, 2024 | P00004 | $-137 | ONCOTYPE DX-DCIS BREAST TEST - ADJUST CLIN QUANTITIES |
| Aug 7, 2024 | P00003 | $0 | OY 1 FY25 ONCOTYPE DX-DCIS BREAST TEST |
| Oct 18, 2023 | P00002 | $124.1K | FY24 FUNDS RELEASE FOR ONCOTYPE DX GENOMIC TESTING SERVICES FOR MAMC, WA FOR 01 OCT 2023 - 30 SEP 2024. |
| Aug 25, 2023 | P00001 | $0 | ONCOTYPE DX GENOMIC TESTING SERVICES FOR MAMC, WA - ADMINISTRATIVE MODIFICATION TO IDENTIFY CLINS 1001-1007, 2001-2007, 3001-3007, AND 4001-4007 AS OPTION CLINS. |
| Aug 23, 2023 | 0 | $0 | ONCOTYPE DX GENOMIC TESTING SERVICES FOR MADIGAN ARMY MEDICAL CENTER, JBLM, WA. |
Estimated positioning window
Sep 30, 2027 – Mar 30, 2028
70/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 70/100. Available recorded signals: 65 points.
- Contract end 2028-09-30 (706 days from calculation)
- +25 points
- 85 historical awards in this buyer and category group
- +15 points
- 13 recorded award transactions
- +10 points
- Latest award action: 2026-06-10
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.